DNA immunization: Mechanistic studies

Vaccine

Volumn 17, Issue 13-14, 1999, Pages 1612-1619

  Whitton, J Lindsay ^a   Rodriguez, Fernando ^a   Zhang, Jie ^a   Hassett, Daniel E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; B LYMPHOCYTE; CONFERENCE PAPER; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNIZATION; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 0344938361     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00418-6     Document Type: Conference Paper

References (47)

1. Oxenius A., Bachmann M.F., Mathis D., Benoist C., Zinkernagel R.M., Hengartner H. Functional in vivo MHC class II loading by endogenously synthesized glycoprotein during viral infection. J. Immunol. 158:1997;5717-5726.
2. Oxenius A., Bachmann M.F., Ashton-Rickardt P.G., Tonegawa S., Zinkernagel R.M., Hengartner H. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 25:1995;3402-3411.
3. Weiss S., Bogen B. MHC class II-restricted presentation of intracellular antigen. Cell. 64:1991;767-776.
4. Brooks A., Hartley S., Kjer-Nielsen L., Perera J., Goodnow C.C., Basten A., McCluskey J. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc. Natl. Acad. Sci. USA. 88:1991;3290-3294.
5. Bikoff E.K. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens. J. Immunol. 149:1992;1-8.
6. von Herrath M.G., Yokoyama M., Dockter J., Oldstone M.B.A., Whitton J.L. CD4-deficient mice have reduced levels of memory cytotoxic T-lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol. 70:1996;1072-1079.
7. Henderson D.A. Principles and lessons from the smallpox eradication programme. Bull. World Health Organ. 65:1987;535-546.
8. Hassett D.E., Whitton J.L. DNA Immunization. Trends Microbiol. 4:1996;307-312.
9. Hassett D.E., Zhang J., Whitton J.L. Neonatal DNA immunization with an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol. 71:1997;7881-7888.
10. Whitton J.L., Sheng N., Oldstone M.B.A., McKee T.A. A 'string-of-beads' vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:1993;348-352.
11. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17:1995;79-83.
12. Anonymous. DNA vaccines: a new era in vaccinology. New York: New York Academy of Sciences, 1995.
13. Bishop DHL, Auperin DD. Arenavirus gene structure and organization. In: Oldstone MBA, editor. Arenaviruses: genes, proteins and expression. New York: Springer-Verlag, 1987. p. 5-17.
14. Buchmeier M.J., Oldstone M.B.A. Protein structure of lymphocytic choriomeningitis virus: evidence for a cell associated precursor of the virion glycopeptides. Virology. 99:1979;111-120.
15. Buchmeier M.J., Welsh R.M., Dutko F.J., Oldstone M.B.A. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:1980;275-331.
16. Klavinskis LS, Oldstone MBA, Whitton JL. Designing vaccines to induce cytotoxic T-lymphocytes: protection from lethal viral infection. In: Brown F, Chanock R, Ginsberg H, Lerner R, editors. Vaccines 89. Modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1989. p. 485-9.
17. Klavinskis L.S., Whitton J.L., Oldstone M.B.A. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T-lymphocytes that confer protection from lethal virus infection. J. Virol. 63:1989;4311-4316.
18. Whitton J.L. Lymphocytic choriomeningitis virus CTL. Sem. Virol. 1:1990;257-262.
19. Zarozinski C.C., Fynan E.F., Selin L.K., Robinson H.L., Welsh R.M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:1995;4010-4017.
20. Ulmer J.B., Donnelly J.J., Parker S.E.et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
21. Yokoyama M., Zhang J., Whitton J.L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:1995;2684-2688.
22. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.C. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199:1994;132-140.
23. Sedegah M., Hedstrom R., Hobart P., Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA. 91:1994;9866-9870.
24. Montgomery D.L., Shiver J.W., Leander K.R., Perry H.C., Friedman A., Martinez D., Ulmer J.B., Donnelly J.J., Liu M.A. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12:1993;777-783.
25. Yankauckas M.A., Morrow J.E., Parker S.E., Abai A., Rhodes G.H., Dwarki V.J., Gromkowski S.H. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol. 12:1993;771-776.
26. Schirmbeck R., Bohm W., Ando K., Chisari F.V., Reimann J. Nucleic acid vaccination primes hepatitis B-virus surface antigen-specific cytotoxic T-lymphocytes in nonresponder mice. J. Virol. 69:1995;5929-5934.
27. Hohlfeld R., Engel A.G. The immunobiology of muscle. Immunol. Today. 15:1994;269-274.
28. Hohlfeld R., Goebels N., Engel A.G. Cellular mechanisms in inflammatory myopathies. Clin. Neurol. 2:1993;617-635.
29. Whitton JL, Yokoyama M. Proteins expressed by DNA vaccines induce both local and systemic immune responses. In: Ades EW, Morse SA, Rest RF, editors. Microbial pathogenesis and immune response II. New York: New York Academy of Sciences, 1996. p. 196-206.
30. Yokoyama M., Hassett D.E., Zhang J., Whitton J.L. DNA immunization can stimulate florid local inflammation, and the antiviral immunity induced varies depending on injection site. Vaccine. 15:1997;553-560.
31. Davis H.L., Millan C.L., Watkins S.C. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther. 4:1997;181-188.
32. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1996;1555-1560.
33. Fu T.M., Ulmer J.B., Caulfield M.J., Deck R.R., Friedman A., Wang S., Liu X., Donnelly J.J., Liu M.A. Priming of cytotoxic T-lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3:1997;362-371.
34. Iwasaki A., Torres C.A.T., Ohashi P.S., Robinson H.L., Barber B.H. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159:1997;11-14.
35. Rock K.L. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today. 17:1996;131-137.
36. York I.A., Rock K.L. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:1996;369-396.
37. Rock K.L., Gamble S., Rothstein L. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science. 249:1990;918-921.
38. Torres C.A., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158:1997;4529-4532.
39. Hochstrasser M. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7:1995;215-223.
40. Rodriguez F., Zhang J., Whitton J.L. DNA immunization: ubiquitination of a viral protein enhances CTL induction, and antiviral protection, but abrogates antibody induction. J. Virol. 71:1997;8497-8503.
41. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:1994;761-771.
42. Lanzavecchia A. Antigen presentation by B-lymphocytes: a critical step in T-B collaboration. Curr. Top. Microbiol. Immunol. 130:1986;65-78.
43. Wu Y., Kipps T.J. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T-lymphocytes. J. Immunol. 159:1997;6037-6043.
44. Kagi D., Seiler P., Pavlovic J., Ledermann B., Burki K., Zinkernagel R.M., Hengartner H. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:1995;3256-3262.
45. Kagi D., Vignaux F., Ledermann B., Burki K., Depraetere V., Nagata S., Hengartner H., Golstein P. Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science. 265:1994;528-530.
46. Lowin B., Hahne M., Mattmann C., Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature. 370:1994;650-652.
47. Clark W.R. Perforin-a primary or auxiliary lytic mechanism? Immunol. Today. 9:1988;101-104.